65,437 trials
Esophagus Cancer
Primary: Pathologic Complete Response Rate (PCRR), the Percentage of Patients Who Have No Evidence of Cancer in Their Surgical Specimen Following Surgery — 24 Participants
Breast Cancer
Primary: Proportion of Patients Alive and Without Progression of Disease at 1 Year From Start of Protocol-based Therapy. — 36; 29 percentage of participants
Breast Cancer
Primary: Pathologic Complete Response Rate After Preoperative Therapy in This Patient Population. — 8; 44 percentage of participants
Lactation
Primary: Change in Breast Milk Volume Baseline to 7 Days — -12; 429; 44 % change from baseline
Apathy · Alzheimer's Disease
Primary: Apathy Evaluation Scale (AES) — -1.9; 0.6 units on a scale
Breast Cancer
Primary: Time to Progression of Disease or Death — 7.9; 5.8 Months
Multiple Myeloma
Primary: Toxicity. Number of Patients With Specific Toxicities Are Reported. — 90; 79 percentage of patients
Colorectal Neoplasm
Primary: Estimate of the 6 Month Survival Probability — 49.4; 44.1 Percent chance of survival — p=>0.05
Aortic Diseases
Primary: Composite of Partial or No False Lumen Thrombosis, Aortic Rupture, and Aortic Dilatation — 15; 31 participants — p=<0.001
Lactation
Primary: Breast Milk Production — 66.1 mL/day
Pain · Cancer
Primary: Percentage of Participants Achieving Pain Control — 81.8 Percentage of Participants
Transplant; Failure, Kidney · Renal Disease, End Stage · Hyperparathyroidism, Secondary
Primary: Number of Subjects With Hyperparathyroidism at One Year — 31; 15 Participants — p=0.0005
Heart Failure
Primary: Change in Fecal Sodium Content — 635.10; 501.95 mg — p=0.0662
Heart Failure · Myocardial Ischemia
Primary: Change in Physical Capacity Measured Using the 6-minute Walk Test Distance — 24.5; 21.3 meters
Knee Arthritis
Primary: Alignment of Knee - Measured Mechanical Axis From CT Data — -1.7; -1.3 degrees